Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor and the adenosine system in healthy volunteers
NL-OMON38826Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ticagrelor, sponsored by Radboud University Medical Center. Primary endpoint: Forearm blood flow response to intrabrachial adenosine and forearm ischemia. Started Apr 2013; status: active, not recruiting.
02
Drugs
ticagrelor
Beyond the preview
Go deeper on NL-OMON38826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38826.